Emily Singer commissions and edits scientist-written content and develops new resources for the community. She joined The Transmitter in 2023 and has previously held a variety of editorial roles at the Simons Foundation, including editor for neuroscience collaborations, and senior biology writer and contributing editor at Quanta Magazine. Before joining the foundation, she was biomedical editor at Technology Review.
Emily Singer
Chief opinion editor
The Transmitter
From this contributor
How insights from network theory can boost interdisciplinary efforts
By
Emily Singer
23 February 2026 | 0 min watch
Parents turn their skills to furthering autism research
By
Emily Singer
9 May 2013 | 7 min read
Gender differences take center stage at autism conference
By
Emily Singer
4 May 2013 | 6 min read
Education
- Certificate in science communication, University of California, Santa Cruz
- B.A. in biology, University of California, Santa Cruz
Fellowships
- AAAS Mass Media Fellowship
Explore more from The Transmitter
To understand decision-making, we need to truly challenge lab animals
Complex, multidimensional tasks that unfold over time could reveal how different brain areas work together to support decisions.
To understand decision-making, we need to truly challenge lab animals
Complex, multidimensional tasks that unfold over time could reveal how different brain areas work together to support decisions.
By
Chand Chandrasekaran
20 April 2026 | 6 min read
‘Overdue’ debate unfurls over neuroimaging method
After a January paper questioned the validity of an approach called lesion network mapping, its users are pressure testing their results.
‘Overdue’ debate unfurls over neuroimaging method
After a January paper questioned the validity of an approach called lesion network mapping, its users are pressure testing their results.
By
Angie Voyles Askham
17 April 2026 | 8 min read
Nearly 400 compounds affect behaviors tied to autism-linked genes in zebrafish
Estropipate, paclitaxel and levocarnitine altered behaviors tied to SCN2A and DYRK1A variants specifically, a new open-source platform revealed.
Nearly 400 compounds affect behaviors tied to autism-linked genes in zebrafish
Estropipate, paclitaxel and levocarnitine altered behaviors tied to SCN2A and DYRK1A variants specifically, a new open-source platform revealed.
By
Charles Q. Choi
16 April 2026 | 4 min read